We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

50 hedge funds and large institutions have $151M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

12% more capital invested

Capital invested by funds: $134M → $151M (+$16.8M)

0% more funds holding

Funds holding: 50 → 50 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

59% less call options, than puts

Call options by funds: $281K | Put options by funds: $680K

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
19
Reduced
14
Closed
10
Calls
$281K
Puts
$680K
Net Calls
-$399K
Net Calls Change
+$741K

Top Buyers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
+$6.74M
2
RPAM
Rhenman & Partners Asset Management
Sweden
+$2.43M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$1.77M
4
SFM
Sphera Funds Management
Israel
+$1.55M
5
NIP
Nicholas Investment Partners
California
+$680K

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$6.05M
2
ACP
Acuta Capital Partners
California
-$3.25M
3
GC
GMT Capital
Georgia
-$3.11M
4
RCM
RA Capital Management
Massachusetts
-$2.04M
5
FCMI
Foresite Capital Management III
California
-$1.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$401K +$416K +24,683 New
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$378K -$90.8K -5,388 -19%
PPA
28
Parametric Portfolio Associates
Washington
$375K – – –
Swiss National Bank
29
Swiss National Bank
Switzerland
$371K +$128K +7,600 +50%
State Street
30
State Street
Massachusetts
$320K +$332K +19,709 New
Morgan Stanley
31
Morgan Stanley
New York
$287K -$6.72K -399 -2%
ProShare Advisors
32
ProShare Advisors
Maryland
$262K +$2.91K +173 +1%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$246K +$255K +15,115 New
DCM
34
DAFNA Capital Management
California
$234K +$223K +13,219 +1,100%
Deutsche Bank
35
Deutsche Bank
Germany
$195K +$71K +4,215 +54%
Bank of America
36
Bank of America
North Carolina
$155K +$47K +2,792 +42%
TCIM
37
TIAA CREF Investment Management
New York
$142K +$68.1K +4,041 +86%
VanEck Associates
38
VanEck Associates
New York
$103K -$9.57K -568 -8%
Group One Trading
39
Group One Trading
Illinois
$77K -$57.3K -3,400 -42%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$59K +$60.6K +3,600 New
Simplex Trading
41
Simplex Trading
Illinois
$54K +$29.3K +1,741 +108%
Citigroup
42
Citigroup
New York
$42K -$26.9K -1,594 -38%
UBS Group
43
UBS Group
Switzerland
$23K +$14.5K +863 +159%
PCM
44
Penserra Capital Management
California
$22K +$1.87K +111 +9%
Walleye Trading
45
Walleye Trading
New York
$20K +$20.2K +1,200 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$11K – – –
IWMPD
47
Integrated Wealth Management (Palm Desert)
California
$8K +$8.42K +500 New
Barclays
48
Barclays
United Kingdom
$5K +$3.27K +194 +226%
AIM
49
Acrospire Investment Management
Illinois
$4K -$21.9K -1,300 -85%
FWM
50
Focused Wealth Management
New York
$1K – – –
1
2
3

NDRM Hedge Fund Activity: Q2 2016 in Review

50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q2 2016, worth a combined $151M — up 12% from $134M a quarter earlier.

Fund positioning in NDRM was balanced in Q2 2016: 10 funds opened new positions, 10 closed out, 19 added to existing stakes and 14 trimmed.

The largest buyer was Menora Mivtachim Holdings, adding an estimated $6.74M. The largest seller was Redmile Group, cutting an estimated $6.05M.

  • 50 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $151M of NeuroDerm Ltd. Ordinary Shares stock for Q2 2016, up 12% quarter-over-quarter.
  • 10 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q2 2016 and 10 closed out, a net change of 0 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q2 2016 was Menora Mivtachim Holdings, an estimated $6.74M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q2 2016 was Redmile Group, an estimated $6.05M sold.

Based on aggregated 13F filings for Q2 2016.